NCT07503821 2026-03-31
SYVIPRO
Nantes University Hospital
Phase NA Not yet recruiting
Clinical Trials
7 trialsNCT05059262 2026-03-20
MOTION
Deciphera Pharmaceuticals, LLC
Phase 3 Active not recruiting
NCT04703322 2026-03-04
A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan
Daiichi Sankyo
Phase 2 Active not recruiting
NCT01207492 2026-02-20
Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor
Dana-Farber Cancer Institute
Phase 2 Completed
NCT05417789 2026-02-02
TANGENT
SynOx Therapeutics Limited
Phase 3 Active not recruiting
NCT03069469 2025-12-18
Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor
Deciphera Pharmaceuticals, LLC
Phase 1/2 Active not recruiting
NCT05804045 2025-09-08
Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor (MANEUVER)
Abbisko Therapeutics Co, Ltd
Phase 3 Active not recruiting